Insulet Corp. Stock
Insulet Corp. Stock
There is an upward development for Insulet Corp. compared to yesterday, with an increase of €2.55 (1.760%).
With 60 Buy predictions and 1 Sell predictions Insulet Corp. is one of the favorites of our community.
Based on the current price of 147.05 € the target price of 305 € shows a potential of 107.41% for Insulet Corp. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Insulet Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Insulet Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | 1.760% | -0.989% | 4.537% | -41.282% | -40.561% | -42.651% | -35.717% |
| Haemonetics Corp. | 2.840% | 2.174% | 3.676% | - | 2.920% | - | - |
| CONMED Corp. | 0.000% | -2.094% | 19.872% | -10.952% | 6.857% | -66.000% | -66.903% |
| Penumbra Inc | -0.360% | 0.647% | 0.791% | 42.270% | 5.180% | 0.791% | 29.124% |
Comments
Insulet (PODD) was given a new $210.00 price target by Truist Financial Corporation. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (PODD) had its price target lowered by Royal Bank Of Canada from $280.00 to $245.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (PODD) had its price target lowered by Stifel Nicolaus from $250.00 to $225.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat